JPS6411042B2 - - Google Patents
Info
- Publication number
- JPS6411042B2 JPS6411042B2 JP1253984A JP1253984A JPS6411042B2 JP S6411042 B2 JPS6411042 B2 JP S6411042B2 JP 1253984 A JP1253984 A JP 1253984A JP 1253984 A JP1253984 A JP 1253984A JP S6411042 B2 JPS6411042 B2 JP S6411042B2
- Authority
- JP
- Japan
- Prior art keywords
- pullulan
- pic
- formula
- ether
- integer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229920001218 Pullulan Polymers 0.000 claims description 30
- 239000004373 Pullulan Substances 0.000 claims description 30
- 235000019423 pullulan Nutrition 0.000 claims description 29
- 125000000129 anionic group Chemical group 0.000 claims description 5
- 125000002091 cationic group Chemical group 0.000 claims description 5
- 239000005518 polymer electrolyte Substances 0.000 claims description 2
- 208000036758 Postinfectious cerebellitis Diseases 0.000 description 22
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 4
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 4
- -1 α-aminoacetic acid ester Chemical class 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000002429 anti-coagulating effect Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- GXVUZYLYWKWJIM-UHFFFAOYSA-N 2-(2-aminoethoxy)ethanamine Chemical compound NCCOCCN GXVUZYLYWKWJIM-UHFFFAOYSA-N 0.000 description 1
- YXFNFSBQEDFMHR-UHFFFAOYSA-N 2-(2-sulfoethoxy)ethanesulfonic acid Chemical compound OS(=O)(=O)CCOCCS(O)(=O)=O YXFNFSBQEDFMHR-UHFFFAOYSA-N 0.000 description 1
- MELCWEWUZODSIS-UHFFFAOYSA-N 2-[2-(diethylamino)ethoxy]-n,n-diethylethanamine Chemical compound CCN(CC)CCOCCN(CC)CC MELCWEWUZODSIS-UHFFFAOYSA-N 0.000 description 1
- GTEXIOINCJRBIO-UHFFFAOYSA-N 2-[2-(dimethylamino)ethoxy]-n,n-dimethylethanamine Chemical compound CN(C)CCOCCN(C)C GTEXIOINCJRBIO-UHFFFAOYSA-N 0.000 description 1
- YMDNODNLFSHHCV-UHFFFAOYSA-N 2-chloro-n,n-diethylethanamine Chemical compound CCN(CC)CCCl YMDNODNLFSHHCV-UHFFFAOYSA-N 0.000 description 1
- VMSUVWZFCQSDRU-UHFFFAOYSA-N 3-(3-sulfopropoxy)propane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCOCCCS(O)(=O)=O VMSUVWZFCQSDRU-UHFFFAOYSA-N 0.000 description 1
- SVZCTOUXQOMCQB-UHFFFAOYSA-N 3-[3-(diethylamino)propoxy]-n,n-diethylpropan-1-amine Chemical compound CCN(CC)CCCOCCCN(CC)CC SVZCTOUXQOMCQB-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- PRLDILURXJMICQ-UHFFFAOYSA-N 4-[(4-aminophenyl)methoxymethyl]aniline Chemical compound C1=CC(N)=CC=C1COCC1=CC=C(N)C=C1 PRLDILURXJMICQ-UHFFFAOYSA-N 0.000 description 1
- BCQWMVHBIJJENA-UHFFFAOYSA-N 4-[2-[2-(4-aminophenyl)ethoxy]ethyl]aniline Chemical compound NC1=CC=C(C=C1)CCOCCC1=CC=C(C=C1)N BCQWMVHBIJJENA-UHFFFAOYSA-N 0.000 description 1
- 206010000117 Abnormal behaviour Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- RUUHDEGJEGHQKL-UHFFFAOYSA-N Cl.OC(C[N+](C)(C)C)C Chemical compound Cl.OC(C[N+](C)(C)C)C RUUHDEGJEGHQKL-UHFFFAOYSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- IDTVFVXBUOBQJZ-UHFFFAOYSA-N P(=O)(=O)COCP(=O)=O Chemical compound P(=O)(=O)COCP(=O)=O IDTVFVXBUOBQJZ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N aniline-p-carboxylic acid Natural products NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000002473 artificial blood Substances 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 150000004292 cyclic ethers Chemical class 0.000 description 1
- 239000012799 electrically-conductive coating Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000003014 ion exchange membrane Substances 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- CXHHBNMLPJOKQD-UHFFFAOYSA-N methyl hydrogen carbonate Chemical compound COC(O)=O CXHHBNMLPJOKQD-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- QXMMDJJHCNHQGD-UHFFFAOYSA-N oxido-oxo-[2-(2-phosphoethoxy)ethyl]phosphanium Chemical compound P(=O)(=O)CCOCCP(=O)=O QXMMDJJHCNHQGD-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Landscapes
- Polysaccharides And Polysaccharide Derivatives (AREA)
Description
【発明の詳細な説明】
本発明はプルラン誘導体よりなる高分子電解質
錯体(以下PICと称す)に関するものである。プ
ルランはくり返し単位としてマルトトリオーズよ
りなり、α(1→6),α(1→4)結合を有する
枝分かれのないリニア多糖類高分子であり、水に
容易に溶解しまた安定な水溶液となり、結晶化、
あるいは溶液物性の異常挙動はほとんど認められ
ない。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a polymer electrolyte complex (hereinafter referred to as PIC) comprising a pullulan derivative. Pullulan is an unbranched linear polysaccharide polymer that consists of maltotriose as a repeating unit and has α(1→6) and α(1→4) bonds, and it easily dissolves in water and forms a stable aqueous solution. crystallization,
Alternatively, almost no abnormal behavior in solution physical properties is observed.
醗酵法により工業的に安価に製造されその分子
量なども適当なものが得られる。 It can be produced industrially at low cost by the fermentation method and has a suitable molecular weight.
又PICは、陰イオン性高分子と、陽イオン性高
分子どうしの反応によつてなる物質で、その利用
価値は高い。たとえば、イオン選択透過性、半透
膜性、電気伝導性、抗血液凝固性など有用な特性
を有する。 Furthermore, PIC is a substance formed by the reaction between an anionic polymer and a cationic polymer, and its utility value is high. For example, it has useful properties such as ion selective permeability, semipermeability, electrical conductivity, and anticoagulability.
一方、プルランをのぞいた多糖類のPICの記載
は、特許公報昭53−41718にあり、従来の合成物
とは異なり天然の材料に近いため、生体との親和
性がよく、抗凝血性がすぐれておりさらに酵素に
より分解されやすいので、体内に異物として残る
心配がない等有望な生体親和性材料である。 On the other hand, polysaccharide PICs other than pullulan are described in Patent Publication 1983-41718, and unlike conventional synthetic compounds, they are close to natural materials, have good affinity with living organisms, and have excellent anticoagulant properties. Moreover, since it is easily decomposed by enzymes, it is a promising biocompatible material and there is no need to worry about it remaining as a foreign substance in the body.
しかし、一般的に多糖類は分子量およびその高
次構造が一定でなく、これら多糖類を原料とした
PICは分子設計が困難であり、工業的に均一な製
品を生産するには不適当であつた。このため醗酵
法によつて工業的に生産されており、その分子量
のコントロール等分子設計が容易な水可溶性のリ
ニア多糖類であるデキストランを出発原料とした
PICを発明した(特開昭53−19393)。今発明はデ
キストランの誘導体よりなるPICに負けないすぐ
れた特質を持つプルランの誘導体よりなるPICに
関するものである。以下、この発明を詳細に説明
する。 However, in general, polysaccharides have varying molecular weights and higher-order structures, and when these polysaccharides are used as raw materials,
PIC is difficult to design molecularly and is not suitable for industrially producing uniform products. For this reason, dextran, a water-soluble linear polysaccharide that is industrially produced by fermentation and whose molecular weight can be easily controlled and other molecular designs, is used as a starting material.
Invented PIC (Japanese Patent Application Laid-Open No. 1939-1939). The present invention relates to a PIC made of a pullulan derivative that has superior properties comparable to PIC made of a dextran derivative. This invention will be explained in detail below.
本発明なるプルラン誘導体の新規なPICは、下
記式(1)で示されるプルランの陰イオン性誘導体。 The novel PIC of the pullulan derivative of the present invention is an anionic pullulan derivative represented by the following formula (1).
〔C6H7O2(OH)3−a・(OX)a〕x・H2O (1)
〔式中Xは−SO- 3,−PO-2 3,−(CH2)mR1(た
だしR1は−COO-,−SO- 3,−PO-2 3よりなる群か
ら選ばれた基、mは1〜3の整数)、0<a≦3
の正数、x≧5の整数〕の単位と、
〔C6H7O2(OH)3−b・(OY)b〕y・H2O (2)
〔式中Yは−(CH2)nR2(R2は−NH+ 3,−NH+
(CH3)2,−NH+(C2H5)2,−N+(C2H5)3,−
C6H4・NH+ 3,−CO.C6H4.NH+ 3よりなる群から選
ばれた基、nは1〜3の整数)、又は−CO・R3
(R3は−CH2・NH+ 3又は−C6H4・NH+ 3)、又は−
CH2CH(OH)・CH2R4(R4は−NH+ 3,−NH+
(CH3)2,−NH+(C2H5)2,−N+(C2H5)3からなる
群から選ばれた基)、0<b≦3の正数、y≧5
の整数〕
(2)式で示されるプルランの陽イオン性誘導体の
単位とからなり。上記(1)式で示されるプルランの
陰イオン性誘導体としては、
たとえば、プルランの硫酸エステル、リン酸エ
ステル、カルボキシメチルエーテル、スルホエチ
ルエーテル、スルホプロピルエーテル、ホスホメ
チルエーテル、ホスホエチルエーテルなどが考え
られる。 [C 6 H 7 O 2 (OH) 3 -a・(OX)a]x・H 2 O (1) [In the formula, X is −SO − 3 , −PO −2 3 , −(CH 2 )mR 1 (However, R 1 is a group selected from the group consisting of -COO - , -SO - 3 , -PO -2 3 , m is an integer from 1 to 3), 0<a≦3
a positive number, an integer of x≧5], and the unit of [C 6 H 7 O 2 (OH) 3 −b・(OY)b]y・H 2 O (2) [where Y is −(CH 2 ) nR 2 (R 2 is −NH + 3 , −NH +
(CH 3 ) 2 , −NH + (C 2 H 5 ) 2 , −N + (C 2 H 5 ) 3 , −
C 6 H 4 .NH + 3 , -CO.C 6 H 4 .NH + 3 (n is an integer from 1 to 3), or -CO.R 3
(R 3 is −CH 2・NH + 3 or −C 6 H 4・NH + 3 ), or −
CH 2 CH(OH)・CH 2 R 4 (R 4 is −NH + 3 , −NH +
(CH 3 ) 2 , −NH + (C 2 H 5 ) 2 , −N + (C 2 H 5 ) 3 ), a positive number of 0<b≦3, y≧5
[an integer] It consists of a unit of a cationic derivative of pullulan shown by formula (2). Examples of the anionic derivative of pullulan represented by formula (1) above include pullulan sulfate, phosphate, carboxymethyl ether, sulfoethyl ether, sulfopropyl ether, phosphomethyl ether, and phosphoethyl ether. It will be done.
又、上記(2)式で示される構成単位を生じるプル
ランの陽イオン性誘導体としては、たとえば、プ
ルランのアミノエチルエーテル、ジメチルアミノ
エチルエーテル、ジエチルアミノエチルエーテ
ル、トリエチルアミノエチルエーテルクロリド、
P−アミノベンジルエーテル、P−アミノフエナ
シルエーテル、P−アミノフエニルエチルエーテ
ル、ジエチルアミノプロピルエーテル、αアミノ
酢酸エステル、P−アミノ安息香酸エステル、3
−アミノ−2オキシプロピルエーテル、3−ジメ
チルアミノ−2オキシプロピルエーテル、3−ジ
エチルアミノ−2オキシプロピルエーテル、3−
トリエチルアミノ−2オキシプロピルエーテルク
ロリドなどがあげられる。 In addition, examples of cationic derivatives of pullulan that produce the structural unit represented by formula (2) above include pullulan aminoethyl ether, dimethylaminoethyl ether, diethylaminoethyl ether, triethylaminoethyl ether chloride,
P-aminobenzyl ether, P-aminophenacyl ether, P-aminophenylethyl ether, diethylaminopropyl ether, α-aminoacetic acid ester, P-aminobenzoic acid ester, 3
-amino-2oxypropyl ether, 3-dimethylamino-2oxypropyl ether, 3-diethylamino-2oxypropyl ether, 3-
Examples include triethylamino-2oxypropyl ether chloride.
これらの化合物は、プルランの水酸基の一部あ
るいは全部が、水溶液中で解離して負又は正の電
荷を有する解離基あるいは負又は正の電荷を持ち
得る解離性基で置換されたもので、プルランのエ
ーテル化又はエステル化によつて導入されえる。 These compounds are those in which part or all of the hydroxyl groups of pullulan are substituted with a dissociative group that dissociates in an aqueous solution and becomes negatively or positively charged, or a dissociative group that can carry a negative or positive charge. can be introduced by etherification or esterification of
本発明のPICはプルランの陽イオン性誘導体と
プルランの陰イオン性誘導体を水に溶解し水中で
反応して得られる。 The PIC of the present invention is obtained by dissolving a cationic derivative of pullulan and an anionic derivative of pullulan in water and reacting them in water.
反応条件の1つである濃度は特に制限ないが高
濃度の場合、反応生成物を溶解中より分離する事
が困難な場合があるので0.01〜10%で反応させる
事が望ましい。 The concentration, which is one of the reaction conditions, is not particularly limited, but if the concentration is high, it may be difficult to separate the reaction product from the dissolved product, so it is desirable to carry out the reaction at a concentration of 0.01 to 10%.
反応温度は0〜100℃まで行える。又、反応時
間は適宜選択出来る。生成した沈澱操作により分
離し、充分水洗した後減圧下乾燥して目的物を得
る。 The reaction temperature can be from 0 to 100°C. Moreover, the reaction time can be selected as appropriate. The resulting precipitate is separated by precipitation, thoroughly washed with water, and then dried under reduced pressure to obtain the desired product.
反応にさいしては、プルランの陰イオン性誘導
体の単位とプルランの陽イオン性誘導体の単位と
の比率は適宜選択出きる。すなわち正電荷と負電
荷は完全に中和されてもよいし、正電荷が残つて
いるか、あるいは負電荷が残つていてもよい。 In the reaction, the ratio of the units of the anionic derivative of pullulan to the units of the cationic derivative of pullulan can be selected as appropriate. That is, the positive charges and negative charges may be completely neutralized, or some positive charges or negative charges may remain.
生じたプルランのPICは水、アルコール類ある
いはケトン類、エーテル類などの溶媒に不溶ある
いは難溶である。しかし水−水に混和性の有機溶
媒−酸・塩基あるいは塩の三成分系溶媒に可溶で
ある。ここでいう水に混和性の有機溶媒としては
メタノール、エタノールなどのアルコール類、ア
セトン、メチルエチルケトンなどのケトン類、環
状エーテル類などが考えられる。 The resulting pullulan PIC is insoluble or poorly soluble in solvents such as water, alcohols, ketones, and ethers. However, it is soluble in a ternary solvent consisting of water, a water-miscible organic solvent, and an acid/base or salt. Examples of water-miscible organic solvents here include alcohols such as methanol and ethanol, ketones such as acetone and methyl ethyl ketone, and cyclic ethers.
この発明のPICは粉末で得られるが、必要に応
じて成型品とする事が出来る。例えばこの発明の
PIC粉末を成型機の型に供給し、圧力約10t/cm2
で真空圧縮すると種々のPIC成型品が得られる。
又、前記三成分系溶媒に本発明のPICを溶解さ
せ、たとえば、ガラス板上に塗布して使用する事
も出来る。これらのPICはイオン選択透過性、半
透膜性、電気伝導性あるいは抗血液凝固性などの
性質を有する。 The PIC of this invention can be obtained as a powder, but it can be made into a molded product if necessary. For example, this invention
PIC powder is supplied to the mold of the molding machine, and the pressure is approximately 10t/cm 2
Various PIC molded products can be obtained by vacuum compression.
Further, the PIC of the present invention can be dissolved in the above three-component solvent and used, for example, by coating it on a glass plate. These PICs have properties such as ion selective permeability, semipermeability, electrical conductivity, and anticoagulability.
ゆえにイオン交換膜、過膜、限外過膜、電
気伝導性コーテイング、抗凝血性医療材料あるい
は人工血管、人工角膜などの人工臓器材料として
用いる事ができる。 Therefore, it can be used as an ion exchange membrane, a hypermembrane, an ultramembrane, an electrically conductive coating, an anticoagulant medical material, or an artificial organ material such as an artificial blood vessel or an artificial cornea.
特に、生体に対する親和性がきわめて優れてお
り、人工臓器の材料として好適に使用出来る。 In particular, it has extremely good affinity for living organisms and can be suitably used as a material for artificial organs.
実施例 1
S含量18.3%、分子量MW300000のプルラン硫
酸エステルナトリウム塩の0.2%水溶液とDEAE
プルラン(ジエチルアミノエチル)塩酸塩(N含
量4.8%、分子量MW500000)の0.4%水溶液を同
容量混合させて、水不溶の白色沈澱を生じた。Example 1 0.2% aqueous solution of pullulan sulfate sodium salt with S content 18.3% and molecular weight MW 300000 and DEAE
Equal volumes of 0.4% aqueous solution of pullulan (diethylaminoethyl) hydrochloride (N content 4.8%, molecular weight MW 500000) were mixed to form a water-insoluble white precipitate.
この沈澱を溶液中より分離し、よく水洗した
後、減圧乾燥を行い目的物を得た。 This precipitate was separated from the solution, thoroughly washed with water, and then dried under reduced pressure to obtain the desired product.
収率は23%で、N含量4.6%、S含量8.3%。 Yield was 23%, N content 4.6%, S content 8.3%.
この反応生成物は水不溶であり、Clは検出され
ずプルラン硫酸ナトリウム塩の陰電荷とDEAEプ
ルラン塩酸塩の陽電荷との間の引力によつて静電
的に結合した事を示している。このPICをPIC(1)
と称す。プルラン硫酸エステル(S含量18.3%、
分子量MW40000)以外はすべて同一物、同一条
件で反応させて得たPIC(1b)をつくり、それぞ
れの抗凝血性を下記テスト方法で比較した。 This reaction product was insoluble in water, and no Cl was detected, indicating that it was electrostatically bound by the attractive force between the negative charge of pullulan sulfate sodium salt and the positive charge of DEAE pullulan hydrochloride. This PIC is PIC(1)
It is called. Pullulan sulfate ester (S content 18.3%,
PIC (1b) was prepared by reacting with the same substances and under the same conditions except for the molecular weight (MW 40,000), and the anticoagulant properties of each were compared using the test method described below.
テスト方法
PIC(1)及びPIC(1b)を各100mgずつ成型機の型
に供給し、10t/cm2で真空圧縮して錠剤を作製し
た。この錠剤の表面にACD血液の0.1mlをのせ、
更に0.1M塩化カルシウム0.01mlを加え、時計皿
上にて37℃湯浴で8分間凝結反応をおこさせた
後、生成血栓量を測定する。同一条件でガラス表
面に生じた血栓量を100%とすると、
PIC(1);40%
PIC(1b);80%
となり、分子量に対する依存性が明らかとなり。
分子設計の場合、分子量の影響が重要である。Test method: 100 mg each of PIC (1) and PIC (1b) were fed into the mold of a molding machine and vacuum compressed at 10 t/cm 2 to produce tablets. Place 0.1ml of ACD blood on the surface of this tablet,
Further, 0.01 ml of 0.1M calcium chloride is added, and a coagulation reaction is caused on a watch glass in a 37°C water bath for 8 minutes, after which the amount of thrombus formed is measured. If the amount of blood clots formed on the glass surface under the same conditions is taken as 100%, PIC(1): 40% PIC(1b): 80%, and the dependence on molecular weight becomes clear.
In the case of molecular design, the influence of molecular weight is important.
実施例 2
カルボキシメチルプルランナトリウム塩(カル
ボキシメチル基置換度0.65mol、平均分子量
1000000)の0.3%水溶液と実施例1のDEAEプル
ラン塩酸塩の0.12%水溶液を同容量混合して、白
色沈澱を生成させ、実施例1と同様にして目的物
を得る。Example 2 Carboxymethyl pullulan sodium salt (carboxymethyl group substitution degree 0.65 mol, average molecular weight
A 0.3% aqueous solution of 1,000,000) and a 0.12% aqueous solution of DEAE pullulan hydrochloride of Example 1 are mixed in equal volumes to form a white precipitate, and the desired product is obtained in the same manner as in Example 1.
収率は17%、N含量2.6% −CH2COO-
含量10.6%
実施例 3
カルボキシメチルプルランナトリウム塩(カル
ボキシメチル基置換度0.3、平均分子量MW8000)
を陽イオン交換樹脂(ダウエツクス50W−X8;
ダウケミカル株式会社製)を用い酸型にしたもの
の0.2%水溶液と、DEAEプルラン塩酸塩(N含
量1.4%、平均分子量MW900000)を陰イオン交
換樹脂(アムバーライト400)を用いて塩基型に
したもの0.3%水溶液を同容量混合して沈澱物を
得た。実施例1と同様にして目的物を得る。 Yield is 17%, N content 2.6% -CH 2 COO - content 10.6% Example 3 Carboxymethyl pullulan sodium salt (degree of carboxymethyl group substitution 0.3, average molecular weight MW 8000)
Cation exchange resin (Dowex 50W-X8;
A 0.2% aqueous solution of DEAE pullulan hydrochloride (N content 1.4%, average molecular weight MW 900000) was converted into a base form using an anion exchange resin (Amberlite 400). A precipitate was obtained by mixing the same volume of 0.3% aqueous solution. The target product is obtained in the same manner as in Example 1.
収率18%,N含量0.9%,−CH2COO-含量4.0
実施例 4
プルラン硫酸エステルナトリウム塩(S含量
5.5%、平均分子量MW800000)の0.7%水溶液と
HPTMA−プルラン(2−ヒドロキシプロピル
トリメチルアンモニウム)の塩酸塩(N含量4.9
%、平均分子量MW400000)の0.4%水溶液を同
容量混合して、白色沈澱を生成させる。後実施例
1と同様にして目的物を得る。 Yield 18%, N content 0.9%, -CH 2 COO - content 4.0 Example 4 Pullulan sulfate ester sodium salt (S content
5.5%, average molecular weight MW800000) and 0.7% aqueous solution
HPTMA-Pullulan (2-hydroxypropyltrimethylammonium) hydrochloride (N content 4.9
%, average molecular weight MW 400000) in equal volumes to form a white precipitate. The desired product was obtained in the same manner as in Example 1.
収率20%、N含量4.6%、S含量8.1%。 Yield 20%, N content 4.6%, S content 8.1%.
Claims (1)
(但しR1は−COO-,−SO- 3,−PO-2 3よりなる群か
ら選ばれた基、m=1〜3の整数)、0<a≦3
の正数、xは5以上の整数〕。 (1)式で示され、 プルランの陽イオン性誘導体の単位の式が、 〔C6H7O2(OH)3−b・(OY)b〕y・H2O (2) 〔式中Yは、−(CH2)nR2(R2は−NH3 +,−
NH+(CH3)2,−NH+(C2H5)2,−N+(C2H5)3,−
C6H4・NH3 +,−CO・C6H4・NH+ 3よりなる群か
ら選ばれた基、n=1〜3の整数)、又は、−
COR3(R3は−CH2NH+ 3又は−C6H4・NH+ 3)又は
−CH2CH(OH)・CH2R4(R4は−NH+ 3,−NH+
(CH3)2,−NH+(C2H5)2,−N+(C2H5)3からなる
群から選ばれた基、0<b≦3の整数、y≧5の
整数〕 (2)式で示され、 前記XとYを適宜割合で結合してなる、(1)式と
(2)式より構成される高分子電解質錯体。[Claims] 1. The formula of the unit of the anionic derivative of pullulan is [C 6 H 7 O 2 (OH) 3 -a・(OX)a]x・H 2 O (1) [in the formula is −SO − 3 , −PO −2 3 , −(CH 2 )m・R 1
(However, R 1 is a group selected from the group consisting of -COO - , -SO - 3 , -PO -2 3 , m = an integer of 1 to 3), 0<a≦3
positive number, x is an integer of 5 or more]. It is shown by formula (1), and the formula of the unit of the cationic derivative of pullulan is [C 6 H 7 O 2 (OH) 3 −b・(OY)b]y・H 2 O (2) [in the formula Y is −(CH 2 )nR 2 (R 2 is −NH 3 + , −
NH + (CH 3 ) 2 , −NH + (C 2 H 5 ) 2 , −N + (C 2 H 5 ) 3 , −
a group selected from the group consisting of C 6 H 4・NH 3 + , −CO・C 6 H 4・NH + 3 , n = an integer of 1 to 3), or −
COR 3 (R 3 is −CH 2 NH + 3 or −C 6 H 4・NH + 3 ) or −CH 2 CH(OH)・CH 2 R 4 (R 4 is −NH + 3 , −NH +
(CH 3 ) 2 , -NH + (C 2 H 5 ) 2 , -N + (C 2 H 5 ) 3 , an integer of 0<b≦3, an integer of y≧5] Formula (1), which is represented by formula (2) and is formed by combining the above X and Y in an appropriate ratio,
A polymer electrolyte complex composed of formula (2).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1253984A JPS60156702A (en) | 1984-01-25 | 1984-01-25 | Pullulan polyelectrolyte complex |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1253984A JPS60156702A (en) | 1984-01-25 | 1984-01-25 | Pullulan polyelectrolyte complex |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60156702A JPS60156702A (en) | 1985-08-16 |
| JPS6411042B2 true JPS6411042B2 (en) | 1989-02-23 |
Family
ID=11808131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1253984A Granted JPS60156702A (en) | 1984-01-25 | 1984-01-25 | Pullulan polyelectrolyte complex |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60156702A (en) |
-
1984
- 1984-01-25 JP JP1253984A patent/JPS60156702A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS60156702A (en) | 1985-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0020183B1 (en) | Poly-ion complex, process for its preparation and shaped articles prepared therefrom | |
| JP4230135B2 (en) | Method for producing glycosaminoglycan-collagen complex cross-linked by multifunctional cross-linking agent | |
| KR100507545B1 (en) | Hyaluronic acid derivatives and processes for preparing them | |
| JP4248189B2 (en) | Phosphorylcholine group-containing polysaccharide and method for producing the same | |
| EP2702079A1 (en) | Amphoteric materials based on crosslinked hyaluronic acid, method of preparation thereof, materials containing entrapped active agents, method of preparation thereof, and use of said materials | |
| EP0053473B1 (en) | Cellulose sulfate salt having anti-coagulating action and process for preparing same | |
| CN112812201B (en) | Thiol-modified hyaluronic acid and preparation method and application thereof | |
| EP1659143A1 (en) | Temperature-responsive hydrogel | |
| JPS6411042B2 (en) | ||
| NO131007B (en) | ||
| JP2681669B2 (en) | Novel chitosan compound, its production method and use as a moisturizer | |
| JP2511675B2 (en) | Method for producing polyoxyethylenated chitin | |
| JPS625922B2 (en) | ||
| CN116874830B (en) | A ROMP polymerization cross-linked hyaluronic acid material and its preparation and application | |
| JP2612183B2 (en) | Cellulose derivative and method for producing the same | |
| CN116531550B (en) | Preparation method, product and application of cationized alginic acid hemostatic material | |
| JP2687141B2 (en) | Novel chitosan compound, method for producing the compound, and moisturizing agent containing the compound | |
| JP2986173B2 (en) | Styrene derivative having N-acetylchitooligosaccharide chain and method for producing the same | |
| JP4460662B2 (en) | Hyaluronic acid gel with controlled dissolution rate and method for producing the same | |
| JP2000191703A (en) | Hyaluronic acid gel and method for producing the same | |
| Barbucci et al. | Different sulphation degree and biological performance of hyaluronic acid as heparin‐like molecule | |
| JPS624401B2 (en) | ||
| JP2511676B2 (en) | Process for producing oxide of polyoxyethylenated chitin | |
| CN115703846B (en) | Purification method of hyaluronic acid derivative | |
| EP3533806A1 (en) | Gel composition and method for producing same |